Twist Bioscience Corporation (TWST) News
Follow Twist Bioscience Corporation (TWST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 24 public stories across 18 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Form SCHEDULE 13G/A Twist Bioscience Corp Filed by: FMR LLC
Filed on: November 5, 20
EQUITY | Nov 05, 2026, 06:27 PM UTC
M
Twist Bioscience Shares Gain 10% After Antibody Evaluation Service Announcement
Twist Bioscience announced a service to produce and quickly evaluate antibodies for AI drug discovery research. Shares rose 10% to $175.81 as of midday Wednesday.
EQUITY | Oct 28, 2026, 04:03 PM UTC
M
Twist Bioscience Sets Date to Report Fiscal 2026 Results
Twist Bioscience will report its fiscal 2026 fourth-quarter and full-year results.
EQUITY | Oct 26, 2026, 12:07 PM UTC
H
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Friday. Shares of Humana Inc (NYSE: HUM ) rose sharply after the company said Friday that its 2027 Medicare Advantage Star Ratings improved
LIVE | Oct 09, 2026, 02:51 PM UTC
L
Twist Bioscience Is Maintained at Outperform by Leerink Partners
Ratings actions from Benzinga: GMT) Twist Bioscience Price Target Raised to $190.00/Share From $160.00 by Leerink PartnersRatings actions from Benzinga
NEWS | Sep 29, 2026, 04:36 PM UTC
L
Biotech Stocks At 52-Week Highs - CDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY
WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on September 24, 2026, driven by key catalysts such as reaching certain regulatory milestones or results from clinical trials.CareDx Inc. (CDNA)C
NEWS | Sep 25, 2026, 08:54 AM UTC
M
Twist Bioscience shares rise after deal with Lilly’s TuneLab
Twist Bioscience said it signed a deal with Eli Lilly’s drug discovery platform Lilly TuneLab, sending TWST up 5% to $144.90 Wednesday. The stock has more than quadrupled over the past year.
EQUITY | Sep 16, 2026, 04:01 PM UTC
H
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday. Shares of LuxExperience BV-ADR (NYSE: LUXE ) rose sharply after the company reported fourth-quarter results. LuxExperience reporte
LIVE | Sep 16, 2026, 01:57 PM UTC
L
Cathie Wood Makes Striking Switch Between AI Stock Giants
Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms NASDAQ:META while selling a nearly identical dollar amount of Alphabet NAS
EQUITY | Sep 15, 2026, 12:21 PM UTC
L
TWST price target set at $45 by BWS Financial
EQUITY | Sep 09, 2026, 09:46 PM UTC
L
UBS initiates Twist Bioscience at neutral; sets $144 target
UBS initiated Twist Bioscience at neutral and announced a $144.00/share price target.
EQUITY | Sep 09, 2026, 01:36 PM UTC
L
TWST to Present at Baird 2026 Global Healthcare Conference
Twist Bioscience (TWST) will present at Baird 2026 Global Healthcare Conference.
EQUITY | Sep 09, 2026, 12:05 PM UTC
L
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
AUSTIN, Texas, Sept. 3, 2026 // -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug dis
EQUITY | Sep 03, 2026, 12:55 PM UTC
L
Cathie Wood Drops $124 Million on AI Stocks, Dumps AMD
Cathie Wood Drops $124 Million on AI Stocks, Dumps AMD
EQUITY | Sep 01, 2026, 01:46 AM UTC
L
Twist Bioscience named Anthropic independent evaluator in 8-K
Twist Bioscience says in an 8-K that Anthropic chose the company as one of its independent evaluators to rapidly produce and test AI-designed proteins for binding.
MNA | Aug 19, 2026, 04:56 PM UTC
H
Twist Bioscience Launches $250 Million Stock Offering
Twist Bioscience proposes public offering of common stock
EQUITY | Aug 04, 2026, 08:01 PM UTC
L
Twist Bioscience Sees AI Drug Discovery Pipeline Expand
Twist Bioscience Corporation (NASDAQ: TWST ) stock is up on Monday as the company reported its fiscal 2026 third-quarter financial results and raised fiscal 2026 guidance. The life science company reported an adjusted lo
EARNINGS | Aug 03, 2026, 04:13 PM UTC
L
TWST Twist Bioscience RESULTS: Q3, Q3 REV $118.4M vs. EST $114.5M, Q3 EPS $-0.56, Twist Bioscience Earnings Notes:, Outlook FY REV $456-457M
TWST Twist Bioscience RESULTS: Q3, Q3 REV $118.4M vs. EST $114.5M, Q3 EPS $-0.56, Twist Bioscience Earnings Notes:, Outlook FY REV $456-457M, Outlook Q4 total REV of approximately $123M to $124M, Outlook Q4 to achieve AD
EARNINGS | Aug 03, 2026, 11:21 AM UTC
L
Twist Bioscience Raises FY2026 Sales Guidance from $442.000M-$447.000M to $456.000M-$457.000M vs $446.103M Est
Twist Bioscience (NASDAQ: TWST ) raises FY2026 sales outlook from $442.000 million-$447.000 million to $456.000 million-$457.000 million vs $446.103 million estimate.
EARNINGS | Aug 03, 2026, 11:18 AM UTC
L
TWST - Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
TWST - Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
EARNINGS | Aug 03, 2026, 11:17 AM UTC
H
Implied EPS movers for Monday AM: MAR +/-0.9%, KRYS +/-11.5%, TSN +/-6.6%, TGTX +/-12.0%, TWST +/-18.9%, L +/-4.3%, HESM +/-5.2%, CNH +/-8.0
Implied EPS movers for Monday AM: MAR +/-0.9%, KRYS +/-11.5%, TSN +/-6.6%, TGTX +/-12.0%, TWST +/-18.9%, L +/-4.3%, HESM +/-5.2%, CNH +/-8.0%, MMYT +/-11.7%, CNA +/-5.7%, SRAD +/-13.5%, AVA +/-6.4%, ABTC +/-14.7%, SBH +/
EARNINGS | Jul 31, 2026, 06:05 PM UTC
M
Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ: TWST ) with a Buy and raises the price target from $60 to $107.
EQUITY | Jun 29, 2026, 02:05 PM UTC
M
TWST: Barclays Raises PT
Barclays maintains overweight rating on Twist Bioscience and raises price target to $95
EQUITY | Jun 24, 2026, 02:55 PM UTC
L
TWST Files Mixed Shelf
TWST files a mixed shelf offering with the SEC
EQUITY | Jun 18, 2026, 08:10 PM UTC